{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:57:51Z","timestamp":1790506671743,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T00:00:00Z","timestamp":1528934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008934","name":"Fondation Sana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008934","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00c3\u00b6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["179439"],"award-info":[{"award-number":["179439"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00c3\u00b6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["160108"],"award-info":[{"award-number":["160108"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CM1307"],"award-info":[{"award-number":["CM1307"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ijpddr.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T12:14:02Z","timestamp":1529064842000},"page":"331-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis"],"prefix":"10.1016","volume":"8","author":[{"given":"Reto","family":"Rufener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Ritler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6101-2716","authenticated-orcid":false,"given":"Jana","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson Teixeira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriele","family":"da Silva Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah Elisabeth","family":"Joekel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Czock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Goepfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Marques","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vinicius Nora","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-9556","authenticated-orcid":false,"given":"Meike","family":"Mevissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hemphill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Lundstr\u00f6m-Stadelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2018.06.004_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0889-8553(05)70268-5","volume":"25","author":"Ammann","year":"1996","journal-title":"Cestodes. Echinococcus. Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.11.015","article-title":"Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus","volume":"137","author":"Balasubramanian","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2016.12.058","article-title":"2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine","volume":"127","author":"Barbosa-Lima","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"72","key":"10.1016\/j.ijpddr.2018.06.004_bib5","article-title":"On the importance of targeting parasite stem cells in anti-echinococcosis drug development","volume":"21","author":"Brehm","year":"2014","journal-title":"Parasite Paris Fr"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib6","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1371\/journal.pntd.0000477","article-title":"Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols","volume":"3","author":"Corr\u00eaa Soares","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/014107680710011411","article-title":"A lesson learnt: the rise and fall of Lariam and Halfan","volume":"100","author":"Croft","year":"2007","journal-title":"J. R. Soc. Med."},{"issue":"6","key":"10.1016\/j.ijpddr.2018.06.004_bib8","article-title":"Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?","volume":"2","author":"Croft","year":"2002","journal-title":"BMC Publ. Health"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib9","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1073\/pnas.0402044101","article-title":"Potent block of Cx36 and Cx50 gap junction channels by mefloquine","volume":"101","author":"Cruikshank","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. Sci. Am."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib10","series-title":"Science against Microbial Pathogens: Communicating Current Research and Technological Advances","first-page":"23","article-title":"Mefloquine derivatives\u202f: synthesis, mechanisms of action, antimicrobial activities","author":"Dassonville-Klimpt","year":"2011"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-4017(01)00424-1","article-title":"Veterinary aspects of alveolar echinococcosis\u2013a zoonosis of public health significance","volume":"98","author":"Deplazes","year":"2001","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib12","first-page":"307","article-title":"Massengewinnung und Lagerung von Taenia hydatigena-Eiern sowie Isolierung lebensf\u00e4higer Onkosph\u00e4ren","volume":"128","author":"Deplazes","year":"1988","journal-title":"Schweiz. Arch. Tierheilkd."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/bs.apar.2016.11.001","article-title":"Global distribution of alveolar and cystic echinococcosis","volume":"95","author":"Deplazes","year":"2017","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0014-5793(94)00921-X","article-title":"Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment)","volume":"352","author":"Egan","year":"1994","journal-title":"FEBS Lett."},{"issue":"422","key":"10.1016\/j.ijpddr.2018.06.004_bib15","article-title":"Dogs as victims of their own worms: serodiagnosis of canine alveolar echinococcosis","volume":"10","author":"Frey","year":"2017","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jps.2600830613","article-title":"Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses","volume":"83","author":"Gimenez","year":"1994","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib18","first-page":"1","article-title":"To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis","author":"Gorgas","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14740338.2016.1175428","article-title":"Adverse neuropsychiatric effects of antimalarial drugs","volume":"15","author":"Grabias","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib20","first-page":"1","article-title":"Comprehensive diagnosis and treatment of alveolar echinococcosis: a single-center, long-term observational study of 312 patients in Germany","author":"Gr\u00fcner","year":"2017","journal-title":"GMS Infect. Dis"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib21","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/acs.jmedchem.7b00176","article-title":"Rational design of bisubstrate-type analogues as inhibitors of DNA methyltransferases in cancer cells","volume":"60","author":"Halby","year":"2017","journal-title":"J. Med. Chem."},{"issue":"Pt 2","key":"10.1016\/j.ijpddr.2018.06.004_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S0031182099005351","article-title":"High prevalence of Echinococcus multilocularis in urban red foxes (Vulpes vulpes) and voles (Arvicola terrestris) in the city of Z\u00fcrich, Switzerland","volume":"120","author":"Hofer","year":"2000","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1198\/000313006X118430","article-title":"A lego system for conditional inference","volume":"60","author":"Hothorn","year":"2006","journal-title":"Am. Statistician"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib24","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1128\/AAC.01129-13","article-title":"Disposition of mefloquine and enpiroline is highly influenced by a chronic Schistosoma mansoni infection","volume":"57","author":"Ingram","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib25","first-page":"3531","article-title":"Antimalarials in the treatment of schistosomiasis","volume":"18","author":"Keiser","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/bs.apar.2016.09.006","article-title":"The echinococcoses: diagnosis, clinical management and burden of disease","volume":"96","author":"Kern","year":"2017","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib27","first-page":"119","article-title":"Critical appraisal of nitazoxanide for the treatment of alveolar echinococcosis","volume":"79","author":"Kern","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib28","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/AAC.44.4.848-852.2000","article-title":"Antimicrobial activities of mefloquine and a series of related compounds","volume":"44","author":"Kunin","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijantimicag.2013.09.012","article-title":"Amino ozonides exhibit in vitro activity against Echinococcus multilocularis metacestodes","volume":"43","author":"K\u00fcster","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.01392-10","article-title":"In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis","volume":"55","author":"K\u00fcster","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijantimicag.2015.07.016","article-title":"Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin","volume":"46","author":"K\u00fcster","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0169-4758(90)90227-U","article-title":"Mode of action of benzimidazoles","volume":"6","author":"Lacey","year":"1990","journal-title":"Parasitol. Today Pers. Ed"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib34","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1021\/jm900003c","article-title":"Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis","volume":"52","author":"Lilienkampf","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1440-1681.1985.tb00904.x","article-title":"The anticholinesterase activity of mefloquine","volume":"12","author":"Lim","year":"1985","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bbrc.2016.01.046","article-title":"Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K\/Akt\/mTOR signaling pathway","volume":"470","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1139\/z69-161","article-title":"Attempts at chemotherapy of Echinococcus multilocularis infections in rodents","volume":"47","author":"Lubinsky","year":"1969","journal-title":"Can. J. Zool."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1017\/S0031182011002204","article-title":"Mefloquine interferes with glycolysis in schistosomula of Schistosoma mansoni via inhibition of enolase","volume":"139","author":"Manneck","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib39","first-page":"579","article-title":"Mefloquine use, psychosis, and violence: a retinoid toxicity hypothesis","volume":"19","author":"Mawson","year":"2013","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.neuropharm.2005.06.011","article-title":"Mefloquine inhibits cholinesterases at the mouse neuromuscular junction","volume":"49","author":"McArdle","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib41","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1128\/AAC.02883-15","article-title":"Linking murine and human Plasmodium falciparum challenge models in a translational path for antimalarial drug development","volume":"60","author":"McCarthy","year":"2016","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib42","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuro.2011.01.001","article-title":"Mefloquine neurotoxicity is mediated by non-receptor tyrosine kinase","volume":"32","author":"Milatovic","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000238195","article-title":"Multiple-dose kinetic study of mefloquine in healthy male volunteers","volume":"29","author":"Mimica","year":"1983","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40120-016-0045-5","article-title":"Neuropsychiatric adverse reactions to mefloquine: a systematic comparison of prescribing and patient safety guidance in the US, UK, Ireland, Australia, New Zealand, and Canada","volume":"5","author":"Nevin","year":"2016","journal-title":"Neurol. Ther"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40268-016-0167-3","article-title":"Identification of a syndrome class of neuropsychiatric adverse reactions to mefloquine from latent class modeling of FDA adverse event reporting system data","volume":"17","author":"Nevin","year":"2017","journal-title":"Drugs R"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpddr.2014.07.002","article-title":"Repurposing drugs for the treatment and control of helminth infections","volume":"4","author":"Panic","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0035-9203(93)90036-P","article-title":"Steady state pharmacokinetics of mefloquine in long-term travellers","volume":"87","author":"Pennie","year":"1993","journal-title":"Trans. R. Soc. Trop. Med. Hygie"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib48","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1128\/AAC.00476-06","article-title":"In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae","volume":"50","author":"Reuter","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib49","doi-asserted-by":"crossref","first-page":"e0005636","DOI":"10.1371\/journal.pntd.0005636","article-title":"Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions","volume":"11","author":"Ricken","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijantimicag.2016.04.029","article-title":"Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection","volume":"48","author":"Rodrigues-Junior","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.canlet.2012.07.029","article-title":"Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent","volume":"326","author":"Sharma","year":"2012","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib52","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.00553-08","article-title":"In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives","volume":"52","author":"Spicher","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib53","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1128\/AAC.00478-11","article-title":"In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes","volume":"55","author":"Stadelmann","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib54","doi-asserted-by":"crossref","first-page":"e0004535","DOI":"10.1371\/journal.pntd.0004535","article-title":"Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis","volume":"10","author":"Stadelmann","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib55","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jac\/dkp490","article-title":"Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes","volume":"65","author":"Stadelmann","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/clpt.1990.38","article-title":"Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance","volume":"47","author":"Steiger","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1179\/136485909X385036","article-title":"Limitations of amphotericin B and nitazoxanide in the treatment of alveolar echinococcosis","volume":"103","author":"Tappe","year":"2009","journal-title":"Ann. Trop. Med. Parasitology"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib58","doi-asserted-by":"crossref","first-page":"xiii","DOI":"10.1016\/S0065-308X(17)30009-X","volume":"95","author":"Thompson","year":"2017","journal-title":"Preface. Adv. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib59","first-page":"CD006491","article-title":"Mefloquine for preventing malaria during travel to endemic areas","volume":"10","author":"Tickell-Painter","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib60","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1371\/journal.pntd.0000722","article-title":"The global burden of alveolar echinococcosis","volume":"4","author":"Torgerson","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2018.06.004_bib61","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1017\/S0031182007002235","article-title":"Identification of taeniid eggs in the faeces from carnivores based on multiplex PCR using targets in mitochondrial DNA","volume":"134","author":"Trachsel","year":"2007","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2018.06.004_bib62","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/zph.12326","article-title":"Public health follow-up of suspected exposure to echinococcus multilocularis in southwestern Ontario","volume":"64","author":"Trotz-Williams","year":"2017","journal-title":"Zoonoses Public Health"},{"issue":"17031","key":"10.1016\/j.ijpddr.2018.06.004_bib63","article-title":"Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis","volume":"2","author":"Wong","year":"2017","journal-title":"Nat. Microbiol."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320718300617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320718300617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:48:54Z","timestamp":1761922134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320718300617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2211320718300617"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.06.004","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}